biosimilars: comparative analytical assessment
Published 1 month ago • 1K plays • Length 4:39Download video MP4
Download video MP3
Similar videos
-
3:12
biosimilars: critical quality attributes
-
1:58
fda review and approval process for biosimilar medications
-
2:47
biosimilars: approval process
-
2:03
biosimilars interchangeability
-
14:31
biosimilars and interchangeables - regulatory highlights (27of33) quality – oct. 16-17, 2019
-
6:32
biosimilars: totality of the evidence in biosimilar development
-
4:12
the basics of biosimilars
-
42:43
regulatory highlights for biosimilars and interchangeables (9of15) redi – may 29-30, 2019
-
1:01:34
what's in an ind? guide to writing ind for biologics
-
5:04:58
continual improvement of cder bla submission, assessment, and facility readiness/inspection
-
3:00
biosimilars: complex copycat drugs
-
3:33
biosimilars: manufacturing and inherent variation
-
5:20
data requirements for biosimilars
-
16:06
data quality expectations for biosimilars with case studies (29of33) quality – oct. 16-17, 2019
-
25:07
office of clinical pharmacology (ocp): biosimilars - bioanalysis 2020
-
24:48
fda perspectives on biosimilar bla-manufacturing (28of33) quality – oct. 16-17, 2019
-
3:07
the promise of biosimilars
-
4:20
the biosimilar development process
-
5:31
biosimilars: the purple book
-
3:03
biosimilar medications — what patients need to know
-
1:00
fda news aug 16th! #biosimilars #medicaldevices #fda #science #training #qualitymanagement #quality